Press Releases

PTC is committed to serving the interests of all our stakeholders.
Pam & Kelsey
Living with PKU, United States

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Mar 28, 2018
PTC Therapeutics Announces Pricing of Public Offering of Common Stock
SOUTH PLAINFIELD, NJ — March 28, 2018 — PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today the pricing of a public offering of 4,000,000 shares of its common stock at a public offering price of $27.04 per share, before underwriting discounts. All of the shares in the offering are to be sold by
Read More
Mar 27, 2018
PTC Therapeutics Announces Proposed Public Offering of Common Stock

SOUTH PLAINFIELD, N.J. , March 27, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today that it is commencing a public offering of 4,000,000 shares of its common stock. All of the shares in the offering are to be sold by PTC. PTC intends to grant the underwriters an option for

Read More
Mar 15, 2018
FIREFISH Transitions into Pivotal Phase
- First patient dosed in Type 1 Spinal Muscular Atrophy Program - SOUTH PLAINFIELD, N.J. , March 15, 2018 /PRNewswire/ --   PTC Therapeutics , Inc. (NASDAQ: PTCT) today announced that the FIREFISH study of RG7916 in Type 1 spinal muscular atrophy (SMA) patients has transitioned into its pivotal
Read More
Mar 01, 2018
PTC Therapeutics To Participate At Upcoming Investor Conferences
SOUTH PLAINFIELD, N.J. , March 1, 2018 /PRNewswire/ --  PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: Cowen and Company 38 th Annual Health Care Conference , on Wednesday, March 14th at 8:00 a.m.
Read More